Pseudoprogression versus true progression in glioblastoma: what neurosurgeons need to know

JS Young, N Al-Adli, K Scotford, S Cha… - Journal of …, 2023 - thejns.org
Management of patients with glioblastoma (GBM) is complex and involves implementing
standard therapies including resection, radiation therapy, and chemotherapy, as well as …

[HTML][HTML] Radiomics: The new promise for differentiating progression, recurrence, pseudoprogression, and radionecrosis in glioma and glioblastoma multiforme

M Alizadeh, N Broomand Lomer, M Azami, M Khalafi… - Cancers, 2023 - mdpi.com
Simple Summary Progression/recurrence, pseudoprogression, and radionecrosis are all
scenarios that can be expected during the treatment course of glioma and GBM. Although …

Hybrid 18F-fluoroethyltyrosine PET and MRI with perfusion to distinguish disease progression from treatment-related change in malignant brain tumors: the quest to …

NJ Smith, TK Deaton, W Territo, B Graner… - Journal of Nuclear …, 2023 - Soc Nuclear Med
Conventional MRI has important limitations when assessing for progression of disease
(POD) versus treatment-related changes (TRC) in patients with malignant brain tumors. We …

[HTML][HTML] MRI radiomics and potential applications to glioblastoma

GW Hooper, DT Ginat - Frontiers in Oncology, 2023 - frontiersin.org
MRI plays an important role in the evaluation of glioblastoma, both at initial diagnosis and
follow up after treatment. Quantitative analysis via radiomics can augment the interpretation …

[HTML][HTML] Diagnostic performance of selected MRI-derived radiomics able to discriminate progression-free and overall survival in patients with midline glioma and the …

MF Chilaca-Rosas, M Garcia-Lezama… - Diagnostics, 2023 - mdpi.com
Background: Radiomics refers to a recent area of knowledge that studies features extracted
from different imaging techniques and subsequently transformed into high-dimensional data …

[HTML][HTML] Diagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: a systematic review and meta-analysis

ZQ Ouyang, GR Zheng, XR Duan… - … Imaging in Medicine …, 2023 - ncbi.nlm.nih.gov
Background Positron emission tomography (PET) imaging is a promising molecular
neuroimaging technique and has been proposed as one of the criteria for glioma …

Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in Differentiating between brain tumor progression versus pseudoprogression …

R Dagher, M Gad, P da Silva de Santana… - Journal of neuro …, 2024 - Springer
Purpose In this study we gathered and analyzed the available evidence regarding 17
different imaging modalities and performed network meta-analysis to find the most effective …

[HTML][HTML] Imaging and Liquid Biopsy for Distinguishing True Progression From Pseudoprogression in Gliomas, Current Advances and Challenges

K Li, Q Zhu, J Yang, Y Zheng, S Du, M Song, Q Peng… - Academic …, 2024 - Elsevier
Rationale and Objectives Gliomas are aggressive brain tumors with a poor prognosis.
Assessing treatment response is challenging because magnetic resonance imaging (MRI) …

[HTML][HTML] Glioblastoma Pseudoprogression Discrimination Using Multiparametric Magnetic Resonance Imaging, Principal Component Analysis, and Supervised and …

JL Thenier-Villa, FR Martínez-Ricarte… - World Neurosurgery, 2024 - Elsevier
Background One of the most frequent phenomena in the follow-up of glioblastoma is
pseudoprogression, present in up to half of cases. The clinical usefulness of discriminating …

[HTML][HTML] The complementary role of MRI and FET PET in high grade gliomas to differentiate recurrence from radionecrosis

A Sahu, R Mathew, R Ashtekar, A Dasgupta… - Frontiers in Nuclear …, 2023 - frontiersin.org
Background Conventional magnetic resonance imaging (MRI) has limitations in
differentiating tumor recurrence (TR) from radionecrosis (RN) in high grade gliomas (HGG) …